CD30 ligand is a new therapeutic target for central nervous system autoimmunity

Koji Shinoda, Xun Sun, Akiko Oyamada, Hisakata Yamada, Hiromi Muta, Eckhard R. Podack, Jun ichi Kira, Yasunobu Yoshikai

Research output: Contribution to journalArticlepeer-review

14 Scopus citations

Fingerprint

Dive into the research topics of 'CD30 ligand is a new therapeutic target for central nervous system autoimmunity'. Together they form a unique fingerprint.

Medicine & Life Sciences